Nexocure Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Nexocure Therapeutics General Information
Description
Developer of novel therapeutics designed for inflammatory diseases by using exosomes as delivery vehicles for advanced drugs. The company is currently operating in Stealth Mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- Gothenburg
- Sweden
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
- Gothenburg
- Sweden
Nexocure Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 29-Oct-2024 | Completed | Stealth |
Nexocure Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| GU Ventures | Accelerator/Incubator | Minority |
Nexocure Therapeutics FAQs
-
Where is Nexocure Therapeutics headquartered?
Nexocure Therapeutics is headquartered in Gothenburg, Sweden.
-
What industry is Nexocure Therapeutics in?
Nexocure Therapeutics’s primary industry is Biotechnology.
-
Is Nexocure Therapeutics a private or public company?
Nexocure Therapeutics is a Private company.
-
What is Nexocure Therapeutics’s current revenue?
The current revenue for Nexocure Therapeutics is .
-
Who are Nexocure Therapeutics’s investors?
GU Ventures has invested in Nexocure Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process